Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Origin Capital Nominees Limited investment portfolio
Origin Capital Nominees Limited has made numerous investments in companies such as Echion Technologies, Vianautis Bio, and Cytal Uk within the Healthcare & Life Sciences sector.
vc
Portfolio
4
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (4)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Cytal Uk Limited CyTAL UK Ltd develops and delivers cyber‑security assurance solutions, including the ProtoCrawler fuzz‑testing platform that identifies and mitigates vulnerabilities in IT/OT products such as industrial control systems, smart‑energy devices and physical‑security systems. It also provides consultancy, product assurance and testing services to help developers, manufacturers and their customers improve the security and resilience of critical infrastructure. | Software & IT | Peterborough | Confirmed | 2026-06-02 |
| Echion Technologies Ltd Echion Technologies Ltd develops high‑power niobium‑based anode materials (XNO®) for lithium‑ion batteries that deliver super‑fast charging, high safety and long cycle life, targeting electric‑mobility, industrial and consumer battery applications. | Healthcare & Life Sciences | Sawston | Confirmed | 2025-04-04 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (3)
Origin Capital Nominees Limited's positions across portfolio companies2026
- SERIES B-2 0 → 18,868
2023
- SERIES A2 PREFERRED 0 → 22,369